Innovative Approaches for Developing Timely, Accurate Tests to Drive Lyme Disease Diagnostics Market Past US$ 2.87 Bn by 2031: TMR Study

- Demand for advanced serological assays and research in cytokine-based immunoassays to help reduce prevalence of Lyme disease; players focus on launching more sensitive tests

- Substantial need of clinical laboratory tests offers lucrative gains to Lyme disease diagnostics market players

ALBANY, N.Y., Sept. 13, 2021 /PRNewswire/ -- The relentless efforts by clinical assay developers to improve the specificity and sensitivity of tests for diagnosing Lyme disease have underpinned the recent advancements in the Lyme disease diagnostics market. Extensive R&D in metabolic biomarkers and biosignatures have helped companies unveil products for earlier-stage diagnosis. New approaches to lab testing for Lyme disease have stridently led to advanced serological testing, expanding the Lyme disease diagnostics market outlook.

All these factors are expected to drive the global valuation of the market past US$ 2.87 Bn by 2031. Lyme disease, a common vector-borne disease, has shown marked prevalence, finds a study by TMR on the Lyme disease diagnostics market. Untreated cases have found to be associated with implications of adverse neurological, musculoskeletal, and skin-related conditions in the patient population, thereby intensifying the need for early detection of the disease.

Strong expertise with attention to detail makes our market research reports stand apart, Request a Report Sample at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1658

 Key Findings of Lyme Disease Diagnostics Market Study

• Adequate Management of Tick-bitten Patients Helps Reduce Prevalence of Lyme Disease: Prevalence of tick-borne infectious diseases and emergence of vector-borne infections worldwide have driven the demand for adequate management of the patient population. The prevalence is high in Europe and North America, which accounts for the pressing need for timely detection of active B. burgdorferi infection. Advancements in clinical practices for tick-bitten patients has allowed the healthcare industry to harness diagnostics for detecting as well monitoring the incidence of Lyme disease, thereby expanding the avenue for assay developers, notes a market study on the Lyme disease diagnostics market. New technologies that overcome technical and biological shortcomings of the current assays are emerging, which will enrich the value chain of players in the Lyme disease diagnostics market in the near future.
• New Approaches for Lab Tests for Lyme Disease Pave Way for Timely, Accurate Diagnosis of Lyme Disease: The past few years have witnessed many players focusing on improving the serological testing, which is frequently used for the diagnosis of the Lyme disease. Ongoing efforts to increase the specificity and sensitivity of such tests have opened up promising avenues, notes the study on the Lyme disease diagnostics market. Evolving clinical studies on cytokine-based immunoassays hold promising potentials in the reliable detection of the Lyme disease, and play a significant role in its timely treatment.
• Demand for Diagnostics in Clinical Laboratories Offers Lucrative Avenues: Serological assays are currently the mainstay of Lyme disease diagnostics, and the serological testing segment held major market share in 2020. Apart from the prevalent use of serological tests, Lyme disease is diagnosed using polymerase chain reaction (PCR) testing, lymphocyte transformation test, urine antigen testing, and immunofluorescence (IFA). The unmet medical need for reliable and rapid direct-detection methods for emerging B. burgdorferi infections, the etiologic agent of Lyme disease, will spur research in developing new methods for clinical lab applications. In particular, various studies have demonstrated PCR-based assays and next-generation sequencing to hold potential in direct-diagnostic methods in clinical applications.

Request for Analysis of COVID-19 Impact on Lyme Disease Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1658

Lyme Disease Diagnostics Market: Drivers

• Growing awareness about rising cases of Lyme disease is a key driver of the Lyme disease diagnostics market. Public health agencies in some countries have relied on standard national surveillance methods to understand the prevalence of the disease.
• Constant improvements in clinical lab infrastructures in developing regions are bolstering access to reliable tests for diagnosing the Lyme disease. The trend is underpinned by incessant research on molecular diagnostics for emerging infectious diseases.
• Lyme Disease Diagnostics Market: Regional Growth Dynamics
• North America held major share of the Lyme disease diagnostics market in 2020. There has been a marked rise in Lyme disease cases in the U.S. The region has witnessed Lyme disease as one of the most commonly reported vector-borne diseases. Consequently, this has spurred research in developing accurate diagnostics, fueling growth opportunities in the regional market.
• The Europe Lyme disease diagnostics market is projected to rise at remarkable CAGR from 2021 to 2031. New approaches in the detection of B. burgdorferi infections will expand the revenue potential for market players in Europe.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, ask for custom research at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1658

Lyme Disease Diagnostics Market: Key Players

Some of the key industry players in the Lyme disease diagnostics market are Cenogenics Corporation, Galaxy Diagnostics, PerkinElmer Inc., Lyme Diagnostics Ltd., Bio-Rad Laboratories, and QIAGEN.

Global Lyme Disease Diagnostics Market: Segmentation

• Lyme Disease Diagnostics Market, by Diagnostic Test
• Serological Test
• ELISA
• Western Blot
• Polymerase Chain Reaction (PCR) Testing
• Immunofluorescence (IFA)
• Lymphocyte Transformation Test
• Urine Antigen Testing
• Others
• Lyme Disease Diagnostics Market, by Sample
• Blood
• Cerebrospinal Fluid (CSF)
• Joint Fluid
• Urine
• Lyme Disease Diagnostics Market, by End User
• Hospitals
• Clinical Laboratories
• Physician Clinics
• Others
• Lyme Disease Diagnostics Market, by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific  
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Purchase Premium Research Report on Lyme Disease Diagnostics Market - https://www.transparencymarketresearch.com/checkout.php?rep_id=1658&ltype=S

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research: 

Plasma Protein Therapeutics Market: According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22.41 Bn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027, Growing Investment in Innovation, Rising Demand for Immunoglobulin (IG), Rising Indications and Therapeutic use of Plasma Derived Protein Therapeutics are projected to drive the plasma protein therapeutics market.

Pharmaceutical Excipients Market: The pharmaceutical excipients market is expected to expand at a CAGR of ~5% during the forecast period. However, there are certain challenges such as poor solubility of active pharmaceutical ingredients (APIs) in the formulation of oral solid dosage drugs.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street, 
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/lyme-disease-diagnostic.htm

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg